The role of nitric oxide and cyclooxygenase-2 in attenuating apoptosis

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 21, Issue 2, 2002, Pages 103-112

  Brüne, Bernhard ^a   Von Knethen, Andreas ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Apoptosis; CAMP; COX 2; NO

Indexed keywords

CASPASE; CYCLIC AMP; CYCLOOXYGENASE 2; CYTOCHROME C; DNA FRAGMENT; GAMMA INTERFERON; GLUTATHIONE DERIVATIVE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; LUCIFERASE; MUTANT PROTEIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OLIGONUCLEOTIDE; PROTEIN BCL 2; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; APOPTOSIS; CELL PROTECTION; CONFERENCE PAPER; CYTOTOXICITY; ENZYME ACTIVATION; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE ACTIVATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ANIMALIA; MURINAE;

EID: 0036084882     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/jenvironpatholtoxicoloncol.v21.i2.30     Document Type: Conference Paper

References (79)

1. Nitric oxide synthases: Roles, tolls, and controls
2. NO at work
3. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
4. Nitric oxide and macrophage function
5. Nitric oxide and the regulation of gene expression
6. The L-arginine-nitric oxide pathway
7. Redox signaling: Nitrosylation and related target interactions of nitric oxide
8. Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress
9. Inducible nitric oxide synthase: What difference does it make?
10. Inducible nitric oxide synthase in human diseases
11. Nitric oxide-mediated apoptosis in murine peritoneal macrophages
12. Nitric oxide synthase induces macrophage death by apoptosis
13. p53 expression in nitric oxide-induced apoptosis
14. Interleukin-1 beta-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells
15. Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds
16. Nitric oxide and its role in apoptosis
17. Nitric oxide (NO): An effector of apoptosis
18. Regulation of the p53 tumor suppressor protein
19. Surfing the p53 network
20. p53: Death star
21. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways
22. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis
23. Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells
24. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
25. Reduced glutathione prevents nitric oxide-induced apoptosis in vascular smooth muscle cells
26. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells
27. Caspases: The executioners of apoptosis
28. p53 accumulation in apoptotic macrophages is an energy demanding process that precedes cytochrome c release in response to nitric oxide
29. Activation of the cell death program by nitric oxide involves inhibition of the proteasome
30. Role of mitogen-activated protein kinases in S-nitrosoglutathione-induced macrophage apoptosis
31. Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2
32. Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide-releasing compound
33. Nitrosative and oxidative stress induced heme oxygenase-1 accumulation in rat mesangial cells
34. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide
35. Protease activation during nitric oxide-induced apoptosis: Comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage
36. No induced apoptosis accompanying the change of oncoprotein expression and the activation of CPP32 protease
37. Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells
38. Bcl-2 protects macrophages from nitric oxide-induced apoptosis
39. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity
40. BCL-2 delay apoptosis and PARP cleavage induced by NO donors in GT1-7 cells
41. Bcl-2 prevents nitric oxide-mediated apoptosis and poly(ADP-ribose) polymerase cleavage
42. Cytokine and low-level nitric oxide prestimulation block p53 accumulation and apoptosis of RAW 264.7 macrophages
43. Cyclooxygenase-2: An essential regulator of NO-mediated apoptosis
44. NO-Evoked macrophage apoptosis is attenuated by cAMP-induced gene expression
45. NF-kappa B and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages
46. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide
47. Superoxide attenuates macrophage apoptosis by NF-kappa B and AP-1 activation that promotes cyclooxygenase-2 expression
48. Superinduction of cyclooxygenase-2 by NO and agonist challenge involves transcriptional regulation mediated by AP-1 activation
49. Attenuation of macrophage apoptosis by the cAMP-signaling system
50. Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression
51. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyctooxygenase-2
52. The role of COX-2 in intestinal cancer
53. Cydooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity
54. Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells
55. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis
56. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells
57. Induction of COX-2 expression by nitric oxide in rheumatoid synovial cells
58. Enhanced expression of haem oxygenase-1 by nitric oxide and anti-inflammatory drugs in NIH 3T3 fibroblasts
59. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
60. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer
61. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
62. Prostaglandin H synthases, nonsteroidal antiinflammatory drugs, and colon cancer
63. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclo-oxygenase 2 (COX-2)
64. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2
65. Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: A possible involvement of cAMP
66. Phorbol ester-like action of staurosporine on the cAMP response to prostaglandin E2 in two macrophage-like cell lines at distinct differentiation stages
67. Fas/APO-1(CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP
68. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3
69. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons
70. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity
71. Adenosine A2a receptor activation delays apoptosis in human neutrophils
72. Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase
73. Analysis of a cAMP-responsive activator reveals a two-component mechanism for transcriptional induction via signal-dependent factors
74. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
75. Ceramide and cyclic adenosine mono-phosphate (cAMP) induce cAMP response element binding protein phosphorylation via distinct signaling pathways while having opposite effects on myeloid cell survival
76. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells
77. CREB is a regulatory target for the protein kinase Akt/PKB
78. Cyclooxygenase-2 and carcinogenesis
79. CREB its associated proteins act as survival factors for human melanoma cells